Smith & Nephew SNATS, Inc. (SNN) Financials
SNN Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | 10.0 billion | 4.8 billion |
| 2023-06-30 | 9.8 billion | 4.6 billion |
| 2023-03-31 | ? | 4.6 billion |
| 2022-12-31 | 10.0 billion | 4.7 billion |
SNN Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | 233.6 million | ? |
| 2023-06-30 | -27.0 million | 9.5 million |
| 2023-03-31 | -27.0 million | 9.5 million |
| 2022-12-31 | 38.0 million | 8.5 million |
SNN Net Income
| Date | Net Income |
|---|---|
| 2023-12-31 | 90.3 million |
| 2023-06-30 | 86.0 million |
| 2023-03-31 | 86.0 million |
| 2022-12-31 | 23.0 million |
SNN Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | 302.0 million | - | 199.0 million |
| 2023-06-30 | 190.0 million | 2.6 billion | 193.0 million |
| 2023-03-31 | 190.0 million | - | - |
| 2022-12-31 | 350.0 million | 2.7 billion | 196.0 million |
SNN Shares Outstanding
SNN Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | 256.6 million | 171.6 million | - | - |
| 2023-06-30 | 83.5 million | 166.0 million | 1.3 billion | - |
| 2023-03-31 | 83.5 million | 83.0 million | - | - |
| 2022-12-31 | 92.5 million | 179.4 million | 376.0 million | 884.5 million |
SNN Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | 2.8 billion | 886.9 million |
| 2023-06-30 | 2.7 billion | 836.0 million |
| 2023-03-31 | 1.4 billion | 418.0 million |
| 2022-12-31 | 2.7 billion | 804.5 million |
SNN
Price: $24.61
Dividend Yield: 0.02%
Forward Dividend Yield: 3.75%
Payout Ratio: 184.80%
Dividend Per Share: 0.92 USD
Earnings Per Share: 0.60 USD
P/E Ratio: 55.06
Exchange: NYQ
Sector: Healthcare
Industry: Medical Devices
Volume: 87632
Ebitda: 1.3 billionMarket Capitalization: 10.8 billion
Average Dividend Frequency: 2
Years Paying Dividends: 25
DGR5: 1.40%
DGR10: 3.77%
DGR20: 8.12%